Free Trial

Acumen Pharmaceuticals (ABOS) Earnings Date, Estimates & Call Transcripts

Acumen Pharmaceuticals logo
$2.52 +0.04 (+1.61%)
Closing price 04:00 PM Eastern
Extended Trading
$2.54 +0.02 (+0.60%)
As of 04:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Acumen Pharmaceuticals Earnings Summary

Acumen Pharmaceuticals posted Q4 2025 earnings on March 26, 2026, reporting an EPS of -$0.41, which topped the consensus estimate of -$0.50 by $0.09. Quarterly revenue was reported to be ($0.09) million. With a trailing EPS of -$2.01,

Upcoming
Earnings Date
May. 12Before Market OpensEstimated
Consensus EPS
(Mar. 26)
-$0.50
Actual EPS
(Mar. 26)
-$0.41 Beat By $0.09
Actual Revenue
(Mar. 26)
-$0.09M

Q4 2025 Earnings Resources

ABOS Upcoming Earnings

Acumen Pharmaceuticals' Q1 2026 earnings is estimated for Tuesday, May 12, 2026, based on past reporting schedules, with a conference call scheduled at 8:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Acumen Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Acumen Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ABOS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Acumen Pharmaceuticals Analyst EPS Estimates

Current Year EPS Consensus Estimate
($1.48) EPS

Acumen Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/12/2026
(Estimated)
-------
3/26/2026Q4 2025-$0.50-$0.41+$0.09-$0.41--$0.09M
11/12/2025Q3 2025-$0.63-$0.44+$0.19-$0.44--
8/12/2025Q2 2025-$0.54-$0.68 -$0.14-$0.68--
5/13/2025Q1 2025-$0.56-$0.48+$0.08-$0.48--
3/27/2025Q4 2024-$0.47-$0.62 -$0.15-$0.62--
11/12/2024Q3 2024-$0.36-$0.50 -$0.14-$0.50--
8/13/2024Q2 2024-$0.28-$0.34 -$0.06-$0.34--
5/20/2024Q1 2024-$0.23-$0.25 -$0.02-$0.25--

Data powered by Fiscal.ai.


This page (NASDAQ:ABOS) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners